We found that ccRCC cell line malignancy could be impaired after restoring the FDX1 expression level, since the proliferation rate of FDX1 overexpression (oeFDX1) was lower than that of the control group (Figure 11D). Here, FDX1 is linked to nonpapillary renal cell carcinoma.